Search research articles
Contact Us
Filters
Showing results (31-40 of 103) with videos related to
Page
of 11
Sort By:
Lancet (London, England)
|
March 26, 1988
Interference in modified immunoradiometric assay for thyrotropin
R D Harvey, K C McHardy, P J Trainer, et al.
The Netherlands Journal of Medicine
|
June 1, 1989
Diagnostic problems caused by spurious elevation of thyrotrophin measured by sensitive assay
R D Harvey, K C McHardy, P J Trainer, et al.
The Journal of Endocrinology
|
April 1, 1994
Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man
G Delitala, P J Trainer, O Oliva, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
February 1, 1993
Urinary free cortisol in the assessment of hydrocortisone replacement therapy
P J Trainer, K C McHardy, R D Harvey, et al.
Clinical Endocrinology
|
September 7, 2007
Wide variation in surgical outcomes for acromegaly in the UK
P R Bates, M N Carson, P J Trainer, et al.
Clinical Endocrinology
|
December 1, 1994
The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers
P J Trainer, J Holly, S Medbak, et al.
Clinical Endocrinology
|
July 1, 1995
Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome
M Korbonits, P J Trainer, R Edwards, et al.
Clinical Endocrinology
|
November 9, 2010
Corticosteroid-binding globulin regulates cortisol pharmacokinetics
I Perogamvros, L Aarons, A G Miller, et al.
Clinical Endocrinology
|
November 21, 2008
Long-term experience of pegvisomant therapy as a treatment for acromegaly
C E Higham, T T Chung, J Lawrance, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2009
Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegaly
C E Higham, S Rowles, D Russell-Jones, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 103) with videos related to
Sort By:
Page
of 11
Lancet (London, England)
|
March 26, 1988
Interference in modified immunoradiometric assay for thyrotropin
R D Harvey, K C McHardy, P J Trainer, et al.
The Netherlands Journal of Medicine
|
June 1, 1989
Diagnostic problems caused by spurious elevation of thyrotrophin measured by sensitive assay
R D Harvey, K C McHardy, P J Trainer, et al.
The Journal of Endocrinology
|
April 1, 1994
Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man
G Delitala, P J Trainer, O Oliva, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
February 1, 1993
Urinary free cortisol in the assessment of hydrocortisone replacement therapy
P J Trainer, K C McHardy, R D Harvey, et al.
Clinical Endocrinology
|
September 7, 2007
Wide variation in surgical outcomes for acromegaly in the UK
P R Bates, M N Carson, P J Trainer, et al.
Clinical Endocrinology
|
December 1, 1994
The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers
P J Trainer, J Holly, S Medbak, et al.
Clinical Endocrinology
|
July 1, 1995
Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome
M Korbonits, P J Trainer, R Edwards, et al.
Clinical Endocrinology
|
November 9, 2010
Corticosteroid-binding globulin regulates cortisol pharmacokinetics
I Perogamvros, L Aarons, A G Miller, et al.
Clinical Endocrinology
|
November 21, 2008
Long-term experience of pegvisomant therapy as a treatment for acromegaly
C E Higham, T T Chung, J Lawrance, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2009
Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegaly
C E Higham, S Rowles, D Russell-Jones, et al.
Page
of 11